1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1016/s0924-977x(99)00010-3" target="_blank" rel="noreferrer">http://doi.org/10.1016/s0924-977x(99)00010-3</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children
Publisher
An entity responsible for making the resource available
European Neuropsychopharmacology
Date
A point or period of time associated with an event in the lifecycle of the resource
1999
Subject
The topic of the resource
Child; Humans; Preschool; Biomarkers of Pain; Leukocytes; beta-Endorphin/metabolism; Autistic Disorder/drug therapy/metabolism; Cognition/drug effects; Mononuclear/drug effects/metabolism; Naltrexone/pharmacology/therapeutic use; Narcotic Antagonists/pharmacology/therapeutic use; Stereotyped Behavior/drug effects
Creator
An entity primarily responsible for making the resource
Cazzullo AG; Musetti MC; Musetti L; Bajo S; Sacerdote P; Panerai A
Description
An account of the resource
We assessed the clinical and biological effects of high-dose, long-term Naltrexone (NTX) treatment in 11 children (3-11 years), who had been diagnosed as autistic. The drug was given following an open design, for 12 weeks. Beta-Endorphin (beta-END) was assayed in peripheral blood mononuclear cells after 1 and 3 months of treatment, and 6 months after the completion of the course. Baseline beta-END levels were higher than in healthy age-matched controls. In seven patients treatment reduced beta-END, whose levels rose in four children. Autistic symptoms were considerably attenuated in all cases, with functional improvements involving several areas. There was a close correlation between the reduction in beta-END levels and the decrease of social withdrawal, and an evident--though weak--correlation between increases in beta-END and decreases in stereotypy and abnormal speech. Both effects persisted after treatment stopped.
1999
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/s0924-977x(99)00010-3" target="_blank" rel="noreferrer">10.1016/s0924-977x(99)00010-3</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
1999
Autistic Disorder/drug therapy/metabolism
Backlog
Bajo S
beta-Endorphin/metabolism
Biomarkers of Pain
Cazzullo AG
Child
Cognition/drug effects
European Neuropsychopharmacology
Humans
Journal Article
Leukocytes
Mononuclear/drug effects/metabolism
Musetti L
Musetti MC
Naltrexone/pharmacology/therapeutic use
Narcotic Antagonists/pharmacology/therapeutic use
Panerai A
Preschool
Sacerdote P
Stereotyped Behavior/drug effects